Incidence and outcomes of chronic total occlusion percutaneous coronary intervention in the Netherlands: data from

A van Veelen1, B E P M Claessen2, S Houterman3

  • 1Department of Cardiology, Heart Centre, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Insights

Percutaneous coronary intervention for chronic total occlusions (CTO-PCI) is infrequent. Renal insufficiency is the primary predictor of mortality following CTO-PCI, highlighting the need for risk identification to improve patient outcomes.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Public Health

Background:

  • Patients with chronic total coronary occlusions (CTO) face elevated risks of adverse clinical outcomes.
  • Understanding the incidence of CTO percutaneous coronary intervention (PCI) and identifying high-risk patients is crucial for improving care.

Purpose of the Study:

  • To determine the incidence of CTO percutaneous coronary intervention (PCI) in the Netherlands.
  • To identify predictors of cardiac events and mortality among patients undergoing CTO-PCI.

Main Methods:

  • Analysis of nationwide Netherlands Heart Registration (NHR) data from January 2015 to December 2018, including all non-acute PCI procedures for CTO.
  • Multivariable logistic regression was used to identify risk factors for adverse events, calculating odds ratios (OR) and 95% confidence intervals (CI).

Main Results:

  • CTO-PCI constituted 6.3% of all PCIs, with a significant increasing trend over time.
  • Independent predictors for 1-year mortality after CTO-PCI included renal insufficiency (OR 5.59), low left ventricular ejection fraction (OR 3.43), previous myocardial infarction (OR 1.62), and age (OR 1.06 per year).
  • Renal insufficiency was also a predictor for early coronary artery bypass grafting (OR 2.97) and myocardial infarction (OR 4.70).

Conclusions:

  • CTO-PCI remains infrequently performed in the Netherlands.
  • Renal insufficiency emerged as the most significant predictor of mortality post-CTO-PCI.
  • Identifying high-risk patients, particularly those with renal insufficiency, is essential for future prognostic improvement.
Abstract